72 Investment Holdings, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), 72 Investment Holdings, LLC reported 7 stock positions worth $67.1 million. Its top holding was Korro Bio (KRRO) at 37.1% of the portfolio, followed by Lenz Therapeutics (LENZ, 33.9%) and Alto Neuroscience (ANRO, 15.3%). Compared with Q4 2023, it opened 2 new positions and sold out of 1. The biggest buy was a new position in Lenz Therapeutics (LENZ) and the biggest sale an exit from Entrada Therapeutics (TRDA).
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $67.1M (Q1 2024)
- SEC Filing
- 0000902664-24-003613 ↗ filed May 15, 2024
Holdings Value
Holdings 7 stocks · $67.1M
| KRRO Korro Bio Inc. | 37.14% | 276,831 | $24.9M | No change |
| LENZ Lenz Therapeutics Inc. | 33.88% | 1,017,751 | $22.7M | New |
| ANRO Alto Neuroscience Inc. | 15.28% | 667,778 | $10.3M | New |
| PRAX Praxis Precision Medicines I | 6.00% | 65,933 | $4.0M | No change |
| CRBU Caribou Biosciences Inc. | 3.63% | 474,067 | $2.4M | No change |
| TSBX Turnstone Biologics Corp. | 2.15% | 549,981 | $1.4M | No change |
| OMGAQ Omega Therapeutics Inc. | 1.92% | 352,941 | $1.3M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| TRDA Entrada Therapeutics Inc. | Sold out | 0.00% | −11.57 |
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |